Seeking Alpha

While Pfizer's (PFE) and J&J's (JNJ) bapineuzumab Alzheimer's drug failed in a Phase III...

While Pfizer's (PFE) and J&J's (JNJ) bapineuzumab Alzheimer's drug failed in a Phase III trial of people who already exhibit symptoms, scientists may yet test it on those at risk of the disease but aren't yet affected. Pfizer and J&J, though, don't yet have plans to assess bapineuzumab for this purpose.
Comments (2)
  • Goeleven
    , contributor
    Comments (629) | Send Message
     
    First t(ime that I here from Bapinuzumab!?
    8 Aug 2012, 03:42 PM Reply Like
  • Goeleven
    , contributor
    Comments (629) | Send Message
     
    Wait and see
    8 Aug 2012, 03:44 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|